Eli Lilly Ownership
| LLY Stock | USD 806.14 12.79 1.56% |
Shares in Circulation | First Issued 1985-09-30 | Previous Quarter 904.2 M | Current Value 905 M | Avarage Shares Outstanding 1.1 B | Quarterly Volatility 72.4 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Eli |
Eli Stock Ownership Analysis
About 84.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.78. Eli Lilly recorded earning per share (EPS) of 9.11. The entity last dividend was issued on the 15th of November 2024. The firm had 2:1 split on the 16th of October 1997. Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana. Eli Lilly operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 35000 people. To find out more about Eli Lilly and contact Jacob Naarden at 317 276 2000 or learn more at https://www.lilly.com.Besides selling stocks to institutional investors, Eli Lilly also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Eli Lilly's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Eli Lilly's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Eli Lilly Quarterly Liabilities And Stockholders Equity |
|
Eli Lilly Insider Trades History
Less than 1% of Eli Lilly and are currently held by insiders. Unlike Eli Lilly's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Eli Lilly's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Eli Lilly's insider trades
Eli Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Eli Lilly is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Eli Lilly and backward and forwards among themselves. Eli Lilly's institutional investor refers to the entity that pools money to purchase Eli Lilly's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-06-30 | 17 M | State Farm Mutual Automobile Ins Co | 2024-06-30 | 12.6 M | International Assets Investment Management, Llc | 2024-09-30 | 12.5 M | Norges Bank | 2024-06-30 | 11 M | Bank Of America Corp | 2024-06-30 | 10.8 M | Wellington Management Company Llp | 2024-06-30 | 10.8 M | Capital Research Global Investors | 2024-06-30 | 9.1 M | Northern Trust Corp | 2024-06-30 | 8.7 M | Capital Research & Mgmt Co - Division 3 | 2024-06-30 | 7.3 M | Lilly Endowment Inc | 2024-09-30 | 96.9 M | Vanguard Group Inc | 2024-06-30 | 73.9 M |
Eli Lilly Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Eli Lilly insiders, such as employees or executives, is commonly permitted as long as it does not rely on Eli Lilly's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Eli Lilly insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Donald Zakrowski over six months ago Payment of 2142 shares by Donald Zakrowski of Eli Lilly subject to Rule 16b-3 | ||
Donald Zakrowski over six months ago Sale by Donald Zakrowski of 670 shares of Eli Lilly | ||
Alfonso Zulueta over a year ago Payment of 9674 shares by Alfonso Zulueta of Eli Lilly subject to Rule 16b-3 | ||
Alfonso Zulueta over a year ago Sale by Alfonso Zulueta of 7000 shares of Eli Lilly |
Eli Lilly's latest congressional trading
Congressional trading in companies like Eli Lilly, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Eli Lilly by those in governmental positions are based on the same information available to the general public.
| 2024-08-21 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
| 2024-08-15 | Representative Josh Gottheimer | Acquired Under $15K | Verify | ||
| 2024-08-14 | Representative Greg Landsman | Acquired Under $15K | Verify | ||
| 2024-07-08 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
| 2024-06-12 | Representative Roger Williams | Acquired Under $15K | Verify | ||
| 2024-05-14 | Senator Tommy Tuberville | Acquired $15K to $50K | Verify | ||
| 2024-04-25 | Representative Dan Newhouse | Acquired Under $15K | Verify | ||
| 2024-02-14 | Senator Tommy Tuberville | Acquired $15K to $50K | Verify | ||
| 2024-02-13 | Senator Tommy Tuberville | Acquired $15K to $50K | Verify | ||
| 2024-01-18 | Senator Sheldon Whitehouse | Acquired Under $15K | Verify | ||
| 2024-01-17 | Senator Sheldon Whitehouse | Acquired Under $15K | Verify | ||
| 2023-11-01 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
| 2023-10-31 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
| 2023-10-17 | Senator Sheldon Whitehouse | Acquired $15K to $50K | Verify | ||
| 2023-10-16 | Senator Sheldon Whitehouse | Acquired $15K to $50K | Verify | ||
| 2023-10-13 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
| 2023-10-12 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
| 2023-10-11 | Senator Markwayne Mullin | Acquired $15K to $50K | Verify | ||
| 2020-10-28 | Representative Kurt Schrader | Acquired Under $15K | Verify | ||
| 2019-03-18 | Representative Alan S Lowenthal | Acquired Under $15K | Verify | ||
| 2019-02-28 | Representative John Rutherford | Acquired Under $15K | Verify | ||
| 2018-09-13 | Representative Zoe Lofgren | Acquired Under $15K | Verify |
Eli Lilly Outstanding Bonds
Eli Lilly issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Eli Lilly uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Eli bonds can be classified according to their maturity, which is the date when Eli Lilly and has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| LILLY ELI 7125 Corp BondUS532457AM04 | View | |
| LILLY ELI 55 Corp BondUS532457AZ17 | View | |
| US532457BS64 Corp BondUS532457BS64 | View | |
| ELI LILLY AND Corp BondUS532457BU11 | View | |
| ELI LILLY AND Corp BondUS532457BT48 | View | |
| LILLY ELI 31 Corp BondUS532457BP26 | View | |
| ELI LILLY AND Corp BondUS532457BZ08 | View | |
| ELI LILLY AND Corp BondUS532457BV93 | View |
Eli Lilly Corporate Filings
F4 | 1st of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 30th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 23rd of October 2024 An amended filing to the original Schedule 13G | ViewVerify |
F3 | 18th of September 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Eli Stock Analysis
When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.